Abbott secures FDA approval for expanded Eterna MRI labeling

By staff writers

May 12, 2023 -- Abbott has secured approval from the U.S. Food and Drug Administration (FDA) for expanded MRI labeling of it Eterna spinal cord stimulation system.

The approval will allow for a wider selection of MRI conditional lead options for full-body scans of people with chronic pain, the company said.

Eterna includes Abbott's TotalScan MRI technology, which allows for faster scan times; its TriCentrus paddle lead, which offers the widest electrical array for 1.5-tesla scanners; and its Penta five-column paddle lead and Octrode stimulation lead, according to the firm.

Copyright © 2023

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking